AxonDAO LLC this week has selected Oracle Cloud Infrastructure (OCI) to build and scale secure GPU infrastructure for artificial intelligence and life sciences workloads. The company stated that the platform will deliver “secure, sovereign, and compliant GPU infrastructure suitable for regulated artificial intelligence, healthcare, and life sciences applications.”
“Trust is becoming the defining requirement for advanced AI and scientific computing,” said Chris Crecelius, founder and chief executive officer of AxonDAO. AxonDAO also said it is transitioning from monetizing GPUs through secondary marketplaces to offering “direct, infrastructure enforced compute services designed for sensitive, human origin data.”
The deployment will run in Oracle Cloud regions located in the United States. The company said this reduces exposure to cross-border data replication risks. It also stated that the environment uses customer-managed encryption key capabilities available within OCI and is configured to prevent the creation of unencrypted data.



